Emergence and Characterization of a Ceftriaxone-Resistant Neisseria gonorrhoeae FC428 Clone Evolving Moderate-Level Resistance to Azithromycin in Shenzhen, China

Infect Drug Resist. 2021 Oct 19:14:4271-4276. doi: 10.2147/IDR.S336212. eCollection 2021.

Abstract

We here described a ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone (YL201) with moderate-level resistance to azithromycin in Shenzhen, South China in 2020. The NG-STAR type of YL201 is ST2238, containing a mosaic penA-60.001 allele, which is a typical characteristic of FC428 clone. YL201 harbours four copies of the 23S rRNA C2611T mutation, conferring moderate-level resistance to azithromycin. The MLST type is ST1600, identical with two N. gonorrhoeae FC428 clones identified in Hangzhou. Genome-wide phylogeny analysis demonstrates that YL201 is clustered with other FC428 clones from Hangzhou (South-east China) and Chengdu (South-west China). Isolates within this cluster have relatively higher MIC for ceftriaxone and display closely related MLST STs (ST1600 and ST7363) but are different from the ST of typical FC428 clone (ST1903). As ST1600 and ST7363 are common STs in Shenzhen, the further spread of FC428 clones may increase the severity of gonococcal resistance. In summary, identifying a multidrug-resistant (MDR) N. gonorrhoeae isolate in Shenzhen showed FC428 clones have undergone further transmission in China and presented more extensive and concerning antimicrobial resistance (AMR) characteristics during the spread.

Keywords: Neisseria gonorrhoeae; antimicrobial resistance; azithromycin; ceftriaxone; phylogeny.

Grants and funding

This study was supported by CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-3-021); the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT310-004); the National Science and Technology Infrastructure of China (Project No. National Pathogen Resource Center-NPRC-32); and the Sanming Project of Medicine in Shenzhen (SZSM201611077).